Compare MGM Resorts International (MGM) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MGM Resorts International vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? MGM Resorts International trades at $29.3 (market cap $7.55B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 3.3× MGM Resorts International's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold MGM Resorts International for 91 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| MGM | RPRX | |
|---|---|---|
Market Cap | $7.55B | $25.27B |
Volume | 5,342,346 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $50.69 | $63.96 |
52-Week Low | $30.00 | $35.44 |
Typical Hold Time | 91 Days | 1 Days |
Enterprise Value | $34.85B | $32.50B |
Dividend Yield | 0.03% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MGM Resorts International (MGM) stock is trading at $29.27, down 2.43% on the day and reflecting significant pressure following the collapse of Barry Diller's $48.30 per share acquisition proposal in late September 2026. The technical picture is bearish, while fundamentals show mixed signals with revenue growth to $17.54B in 2025 but declining net income margins. Analyst sentiment remains predominantly positive with a consensus price target of $48.75, suggesting substantial upside potential from current levels.
The investment case hinges on MGM's ability to execute its strategic initiatives and potentially pursue acquisitions like People Inc. to unlock value. Near-term risks include integration challenges, market volatility, and execution missteps. The current valuation at a P/E of 18.19 and P/S of 0.45 appears reasonable if management can stabilize profitability and navigate the post-deal uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
